🇺🇸 FDA
Pipeline program

50 mcg Duramorph+ EXPAREL + multi-modal pain regimen

402-C-414

Approved small_molecule completed

Quick answer

50 mcg Duramorph+ EXPAREL + multi-modal pain regimen for Elective Cesarean Section is a Approved program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Pacira BioSciences
Indication
Elective Cesarean Section
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials